Back To Search Instructions
Protocols
21 protocols meet the specified criteria
Disease Site: Other
Protocol No.TitleStatus
0100000331Neuroblastoma Biology StudiesOpen
0500000226Arizona Lymphoid Tissue and Blood Repository (ALTBR)Open
0600000101Sentinel Lymph Node Working Group Data Acquisition ProjectOpen
0600000665COG AREN0321: Treatment of High Risk Renal Tumors: A Groupwide Phase II StudyOpen
0600000878COG AREN0532: Treatment for Very Low, Low, and Standard Risk Favorable Histology Wilms Tumor: A Groupwide Phase III StudyOpen
0700000414COG AREN0533: Treatment of Newly Diagnosed Higher Risk Favorable Histology Wilms TumorOpen
0800001063Pilot Study to Examine the Effect of Over-the-Counter Supplements on Blood Nutrient LevelsOpen
1000000393Treatment of Recurrent or Resistant Pediatric Malignant Germ Cell Tumors with Paclitaxel, Ifosfamide and Carboplatin (COG AGCT0521)Open
1100000212Skin Cancer Institute Patient Registry and Tissue BankOpen
1100000353A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects with Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma (M12-175) Open
1100000429Phase 1b, Escalating Dose Study of AVL-292, a Bruton's Tyrosine Kinase (Btk) Inhibitor, as Monotherapy in Subjects with Relapsed and/or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's MacroglobulinemiaOpen
1100000610A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) for transplantation in pediatric and adult patients with hematologic malignancies and other indicationsOpen
12-1026-04LyP RegistryOpen
1200000148A multicenter safety study of unlicensed investigational cryopreserved cord blood units (CBUs) manufactured by the National Cord Blood Program (NCBP) and provided for unrelated hematopoietic stem cell transplantation of pediatric and adult patientsOpen
1200000229Skin Cancer Prevention Program BiorepositoryOpen
1300000422CALGB90601: A Randomized Double-Blinded, Placebo-Controlled Phase III Study Comparing Gemcitabine, Cisplatin, and Bevacizumab to Gemcitabine, Cisplatin, and Placebo in Patients with Advanced Transitional Cell Carcinoma Open
1300000696Optimal timing of initial PET/CT surveillance after definitive radiotherapy for head and neck cancersOpen
1300000720Role of concurrent systemic therapy with adjuvant radiation therapy for locally advanced cutaneous squamous cell carcinoma at the University of Arizona Radiation Oncology ClinicOpen
1401183410A Placebo Controlled Double-Blind Study to Evaluate the Efficacy of vismodegib as Chemoprevention of New Bcc Development in High Risk SubjectsOpen
1402211338XL184308 A Phase 3, Randomized, Controlled Study of Cabozantinib (XL184) vs Everolimus in Subjects with Metastatic Renal Cell Carcinoma that has Progressed after Prior VEGFR Tyrosine Kinase Inhibitor TherapyOpen
EPICTESTEpic Test Production 5-13-2014Open